Dupixent’s Hidden Risks

Are Coming to Light

Patients are now speaking out – will you?

Dupixent was prescribed to help with severe skin conditions and allergies. But for some, it has been linked to serious risks, including cutaneous T-cell lymphoma (CTCL).

What was meant to bring relief may have caused lasting harm. Drugmakers failed to fully warn patients, leaving many to face devastating health challenges.

If you or a loved one developed CTCL after using Dupixent, you are not alone. Time is limited. Take action today. Our team is here to listen and fight for your justice.

You may be eligible for compensation

Join the Fight for Justice

Have you used Dupixent (Dupilumab) for eczema, asthma, or another condition? *

After using Dupxient, were you later diagnosed with Cutaneous T-Cell Lymphoma (CTCL) or a related lymphoma? *

First Name *

Last Name *

Email *

Phone *

Postal code *

Are you currently working with an attorney for this case?

Additional Notes (optional)

By selecting Submit and completing this form I confirm that I am over 18 and am providing consent to permit Litigation Notification and Reciprocity Industries to contact me at the number provided via autodialer, prerecorded/artificial voice, text/SMS messaging (std.msg/data rates apply) and refer me along to an attorney or other advocate, Std. msg rates apply. I acknowledge my consent to such contact is not required to obtain legal services. I have read and agree to the Privacy Policy and Disclaimer/Terms, including the arbitration provision.

trusted_form_cert_url

trusted_form_cert_id

The Lasting Impact of Dupixent’s Risks

Patients who trusted Dupixent now face serious and life-altering health struggles, including:

Swollen lymph nodes

Unexplained weight loss

Painful skin lesions and rashes

Tumors and thickened skin

Fevers and night sweats

Chronic fatigue and weakness

What Went Wrong: Abuse Hidden Behind Prison Walls

Across the United States, jails and prisons were built to enforce justice — but for many, they became places of fear, violence, and silence. Abuse by correctional staff, lack of oversight, and deliberate neglect have allowed misconduct to continue for years, often without consequence.

Reports of sexual assault, excessive force, and psychological abuse have emerged from facilities nationwide. Many survivors say they begged for help but were ignored or punished. Others were threatened into silence. In some facilities, staff covered up repeated incidents to protect careers and reputations.

What Went Wrong: Warnings Patients Never Received

Dupixent was marketed as a treatment for severe skin conditions and allergic diseases. But drugmakers failed to fully warn patients of the risks. For some, this meant years of worsening symptoms, delayed diagnoses, and the shocking reality of developing cutaneous T-cell lymphoma (CTCL).

This is more than a side effect. It is a betrayal of trust — and it has left patients and families to deal with devastating consequences.

The Toll of Abuse Behind Bars: Evidence Grows

Survivors are coming forward — and the pattern is undeniable. Sexual abuse in jails and prisons is widespread, long-standing, and often ignored.

A 2024 report documented more than 6,000 allegations of sexual abuse by correctional staff over the past decade. Experts believe the real number is much higher, as many survivors stay silent out of fear. Women and youth are especially at risk and often left unprotected.

For many, the abuse continues long after release — through trauma, shame, and lasting damage.

The Damage Does Not End With Release:

Severe emotional trauma — PTSD, anxiety, and depression often persist for years

Sexual and reproductive health issues — Many survivors face long-term complications

Isolation and broken trust — Fear and shame make it hard to seek support

Substance abuse — A common coping response to unprocessed trauma

Suicidal thoughts or self-harm — Many suffer in silence, without access to care

The Serious Impact of Dupixent’s Risks: Evidence Grows

Patients are speaking out, and the pattern is becoming clear. Medical studies now connect Dupixent with cutaneous T-cell lymphoma (CTCL), a rare but aggressive condition. What was meant to heal has left many facing devastating health challenges.

For patients, the fight doesn’t stop with a diagnosis.

The effects can last for years, including:

Skin lesions and tumors — Painful growths and rashes that spread.

Chronic fatigue — Ongoing weakness that makes daily life harder.

Emotional distress — Fear, stress, and anxiety after diagnosis.

Loss of independence — Simple tasks become difficult to manage.

Family strain — Loved ones carry the weight of ongoing care and worry.

Legal Action Against Dupixent Manufacturers

You may qualify for compensation if you or a loved one developed cutaneous T-cell lymphoma (CTCL) after using Dupixent. Patients describe experiencing painful skin lesions, tumors, and other long-term health issues linked to the drug. Even if your diagnosis came years after starting treatment, your case may still be eligible.

Our team is here to listen, explain your options, and fight for your rights.

Who Might Be Eligible?

You may qualify for compensation if you or a loved one:

• Used Dupixent for eczema, asthma, or related conditions

• Were later diagnosed with cutaneous T-cell lymphoma (CTCL) or its subtypes

• Experienced symptoms such as skin tumors, rashes, or swollen lymph nodes

• Continue to suffer lasting physical or emotional effects

Even if your symptoms developed over time, you may still be eligible. Families of patients who passed away may also be able to take legal action on their behalf.

We are actively reviewing Dupixent cases and can help determine if you qualify for compensation.

The Path Forward

Every Moment Counts.

Take Action Today

The risks of Dupixent are finally coming to light. But awareness alone is not enough. Real accountability requires action.

By stepping forward, you can take control, protect others from facing the same harm, and pursue the justice you deserve. It begins with a free and confidential case review.

If you or a loved one developed cutaneous T-cell lymphoma after using Dupixent, reach out today. Our team will listen, review your case, and guide you through your options. You should not carry this burden alone. Now is the time to take action.

We are here to listen.

We are here to help.

We are here to fight for you.

DISCLAIMER:

This website is for informational purposes only. This is a paid legal advertisement. It does not constitute legal advice, and no attorney-client relationship is formed. The accuracy and completeness of the information cannot be guaranteed. Users should consult with an attorney for advice on their specific legal issues. This information does not constitute medical advice and it should not be relied upon as such. Always consult a doctor before changing any medical regimen. We are not responsible for any actions taken based on the information provided on this site. We strive to help you find information to fight for your rights.